ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
2,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
2,2,Hip fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
2,3,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
3,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
3,2,Therapy change,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
4,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
4,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
4,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
4,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
5,1,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
5,2,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
5,3,Drug delivery system malfunction,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
5,4,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
6,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
6,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
6,3,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
6,4,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
7,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
7,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
8,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
8,2,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
9,1,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
10,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
10,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
10,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
11,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
11,2,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
11,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
11,4,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
11,5,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
12,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
12,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
13,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
13,2,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
14,1,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
15,1,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
16,1,Left ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
17,1,Facial paralysis,Facial cranial nerve disorders,Cranial nerve disorders (excl neoplasms),Nerv,N
17,2,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
17,3,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
17,4,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
18,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
18,2,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
19,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
19,2,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
